ACLS 1 Flashcards
drugs for narrow QRS tachycardia
- verapamil
- Esmolol
- Labetalol
remarks on verapamil
blocks slows calcium channel receptors
indication:
-alternative for adenosine in stabe SVT
-rate controller for stable AF and atrial flutter
2.5-5.0 mg SIVP over 2 mins every 15-30 mins
max dose 20 mg
remarks on esmolol
indication:
-widely used for supraventricular and ventriculararrhythmia
0.5 mg/kg LD over 1min
MD: 0.05-0.20 mg/kg/min
remarks on labetalol
ind:
- widely used for SVT and ventricular arrhythmias
10 mg IV push over 1-2 mins every 10 mins
max 150 mg
drugs for wide QRS tachycardia
- Amiodarone
- Lidocaine
- Magnesiumf
remarks on amiodarone
prolongs action potential duration
decreases AV node conduction
ind:
-supraventricuar and ventricular tachyarrhthmias
150 mg SIVP over 10 mins
1 mg/min infusion over 6 hours
0.5 mg/min infusion for 18 hour
remarks on lidocaine
blocks Na channels in the AV node
ind:
-alternative to amiodarone if amiodarone is not available
1st dose: 1.0-1.5 mg/kg IV bolus
2nd dose: 0.5-0.75 mg/kg IV bolus
remarks on magnesium
indication:
termination. of. Torsades de Pointes
1-2 g in 100 mL D5W
infuse over 1-2 mins
energy level for synchronized cardioversion
narrow regular: 50-100 J
narrow irregular:
150-200 J (biphasic)
200 J (monophasic)
wide regular: 100 J
Wide irregular:
debribillation
management for unstable bradycardia
- atropine
- dopamine infusion
- epineprhine infusion
- transcutaneou pacing
remarks on atropine
1 mg IV bolus every 3-5 mins
max dose 3 mg
remarks on dopamine infusion
5-20 mcg/kg/min iV infusion
remarks on epinephrine infusion
2-10 mcg/min IV infusion
indication for pacing
persistent hemodynamically unstable
- sinus node dysfunction
- 2nd and 3rd degree AV block
refractory to medical therapy
pacing is not recommended for
patients with minimal symptoms without hemodynamic compromise
asystolic cardiac arrest